Read more from the original source: Galera Therapeutics completes acquisition of Nova Pharmaceuticals
Read more from the original source: Galera Therapeutics completes acquisition of Nova Pharmaceuticals
Excerpt from: Oncotelic Therapeutics Implements PDAOAI Platform
The rest is here: Spectral AI Provides Instructions for Retail Investors on Exercising Publicly-Traded Warrants
Continued here: Cocrystal Pharma to Extend Phase 2a Influenza Challenge Study with Oral PB2 inhibitor CC-42344
See the original post: Altamira Therapeutics Announces Successful Nanoparticle-Based Delivery of Circular RNA
Go here to read the rest: Firefly Neuroscience Closes on Financing of up to $12.4 Million
Read the original here: SciSparc Announces Renewal of Approval by Israeli Medical Cannabis Agency for its Clinical Trial in Children with Autism Spectrum Disorder
Here is the original post: HUTCHMED Announces US$608 million Divestment of Non-Core Joint Venture
Dysregulation of mTOR signalling is a converging mechanism in lissencephaly Nature.com
Proof of customer recognition of its quality and mass manufacturing capability PALO ALTO, Calif., Dec. 30, 2024 /PRNewswire/ -- LeadingGMP cell CDMO I Peace, Inc. (https://ipeace.com/en/), specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies,announced that the number of GMP-grade iPS cells manufactured has reached 100 lines.
Recent Comments